Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.370
+0.020 (1.48%)
At close: Apr 1, 2025, 4:00 PM
1.365
-0.005 (-0.36%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Pliant Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-210.3-161.34-123.32-97.26-41.53
Upgrade
Depreciation & Amortization
2.131.841.821.541.31
Upgrade
Loss (Gain) From Sale of Investments
2.51-4.99-1.811.26-
Upgrade
Stock-Based Compensation
37.6344.4822.610.443.9
Upgrade
Other Operating Activities
3.452.391.861.670.27
Upgrade
Change in Accounts Receivable
-1.980.027.28-2.23
Upgrade
Change in Accounts Payable
1.432.97-1.350.890.92
Upgrade
Change in Other Net Operating Assets
7.66-3.75.55-1.26-0.15
Upgrade
Operating Cash Flow
-155.5-116.36-94.63-75.44-37.27
Upgrade
Capital Expenditures
-3.85-0.92-1.76-1.95-1.53
Upgrade
Investment in Securities
144.19-126.09-148.4475.65-209.33
Upgrade
Investing Cash Flow
140.34-127.01-150.273.7-210.87
Upgrade
Long-Term Debt Issued
19.91-9.85--
Upgrade
Net Debt Issued (Repaid)
19.91-9.85--
Upgrade
Issuance of Common Stock
3.21275.25217.562.98161.19
Upgrade
Other Financing Activities
--0.85-0.56-0.46-
Upgrade
Financing Cash Flow
23.12274.41226.852.53213.21
Upgrade
Net Cash Flow
7.9531.03-17.980.78-34.93
Upgrade
Free Cash Flow
-159.35-117.28-96.39-77.4-38.8
Upgrade
Free Cash Flow Margin
--7422.91%-995.26%-1022.13%-92.79%
Upgrade
Free Cash Flow Per Share
-2.63-2.00-2.29-2.16-1.82
Upgrade
Cash Interest Paid
2.621.150.62--
Upgrade
Levered Free Cash Flow
-98.53-66.86-51.12-42.56-23.66
Upgrade
Unlevered Free Cash Flow
-96.64-66.07-50.62-42.56-23.66
Upgrade
Change in Net Working Capital
-10.19-3.62-6.22-8.381.31
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q